Physician profile
Larry C Perez
NPI 1508054719
$3,277.82
in general payments reported to CMS, 2019-2025
8 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $171 · 2021: $529 · 2022: $586 · 2023: $572 · 2024: $663 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,239.79 | 2019-2024 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $824.61 | 2022-2025 | Infuse, Alden Scleral Zenlens, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $346.43 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $283.66 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $277.47 | 2022 | |
| Allergan, INC. | $252.71 | 2021-2022 | |
| Shire North American Group INC | $31.37 | 2019 | |
| Alcon Research LLC | $21.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.